Hematologic Malignancy Fusions
Hematologic Malignancy Fusions is a gene fusion construct representing recurrent chromosomal rearrangements that drive oncogenic mechanisms specifically in blood cell lineages, distinguished from solid tumor fusions by their unique molecular pathologies and hematopoietic context.
305
Publications
18.7K
Citations
2.1K
Authors
621
Institutions
Publications per year
2017–2026
43
Parents
305
1–5 of 305
2.1K
16
h-index
15
h-index
13
h-index
8
h-index
7
h-index
1–5 of 2.1K
621
The University of Tokyo
Tokyo, Japan
18 h-index
77 publications
8.7K citations
University of Chicago
Chicago, United States
12 h-index
69 publications
8.7K citations
Inserm
Paris, France
12 h-index
80 publications
3.6K citations

Lund University
Lund, Sweden
11 h-index
48 publications
2.6K citations

Kyoto Prefectural University of Medicine
Kyoto, Japan
10 h-index
19 publications
812 citations
Heidelberg University
Heidelberg, Germany
9 h-index
43 publications
3.5K citations
Gunma Children's Medical Center
Shibukawa, Japan
9 h-index
14 publications
725 citations
University of Southampton
Southampton, United Kingdom
9 h-index
28 publications
2K citations
1–8 of 621
42 publications · 1.9K citations
29
h-index
BJH · 33 publications · 1.4K citations
25
h-index
Repository · 24 publications · 1.7K citations
21
h-index
PNAS · 17 publications · 3.2K citations
17
h-index
16 publications · 1.2K citations
15
h-index
1–5